166 related articles for article (PubMed ID: 18029833)
21. Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
Im HJ; Yoon HJ; Lee ES; Kim TS; Kim JY; Chung JK; Kim SK; Park SY
Nucl Med Commun; 2014 Mar; 35(3):268-75. PubMed ID: 24253568
[TBL] [Abstract][Full Text] [Related]
22. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2007 Oct; 110(8):1738-44. PubMed ID: 17786947
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
[TBL] [Abstract][Full Text] [Related]
24. FDG-PET in carcinoma of the uterine cervix with endometrial extension.
Hope AJ; Saha P; Grigsby PW
Cancer; 2006 Jan; 106(1):196-200. PubMed ID: 16302228
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography or PET-computed tomography in cervical cancer: a meta-analysis.
Zhao Q; Feng Y; Mao X; Qie M
Int J Gynecol Cancer; 2013 Sep; 23(7):1184-90. PubMed ID: 23851677
[TBL] [Abstract][Full Text] [Related]
26. FDG PET/MR Imaging Coregistration Helps Predict Survival in Patients with Glioblastoma and Radiologic Progression after Standard of Care Treatment.
Leiva-Salinas C; Schiff D; Flors L; Patrie JT; Rehm PK
Radiology; 2017 May; 283(2):508-514. PubMed ID: 28234553
[TBL] [Abstract][Full Text] [Related]
27. Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.
Grigsby PW; Mutch DG; Rader J; Herzog TJ; Zoberi I; Siegel BA; Dehdashti F
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):444-9. PubMed ID: 15667965
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
Hoekstra CJ; Stroobants SG; Smit EF; Vansteenkiste J; van Tinteren H; Postmus PE; Golding RP; Biesma B; Schramel FJ; van Zandwijk N; Lammertsma AA; Hoekstra OS
J Clin Oncol; 2005 Nov; 23(33):8362-70. PubMed ID: 16293866
[TBL] [Abstract][Full Text] [Related]
29. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis.
Belhocine TZ
J Nucl Med; 2004 Oct; 45(10):1602-4. PubMed ID: 15471821
[No Abstract] [Full Text] [Related]
31. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix.
Lin LL; Mutic S; Malyapa RS; Low DA; Miller TR; Vicic M; Laforest R; Zoberi I; Grigsby PW
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1494-501. PubMed ID: 16154713
[TBL] [Abstract][Full Text] [Related]
32. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
[TBL] [Abstract][Full Text] [Related]
33. Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
Kim MK; Ryu JS; Kim SB; Ahn JH; Kim SY; Park SI; Kim YH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
Eur J Cancer; 2007 Jun; 43(9):1385-91. PubMed ID: 17512192
[TBL] [Abstract][Full Text] [Related]
34. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.
Sakurai H; Suzuki Y; Nonaka T; Ishikawa H; Shioya M; Kiyohara H; Katoh H; Nakayama Y; Hasegawa M; Nakano T
Gynecol Oncol; 2006 Mar; 100(3):601-7. PubMed ID: 16257440
[TBL] [Abstract][Full Text] [Related]
35. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy.
Nakamoto Y; Eisbruch A; Achtyes ED; Sugawara Y; Reynolds KR; Johnston CM; Wahl RL
Gynecol Oncol; 2002 Feb; 84(2):289-95. PubMed ID: 11812089
[TBL] [Abstract][Full Text] [Related]
37. Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.
Miller TR; Pinkus E; Dehdashti F; Grigsby PW
J Nucl Med; 2003 Feb; 44(2):192-7. PubMed ID: 12571208
[TBL] [Abstract][Full Text] [Related]
38. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
[TBL] [Abstract][Full Text] [Related]
39. Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?
Akkas BE; Demirel BB; Dizman A; Vural GU
Ann Nucl Med; 2013 Oct; 27(8):756-63. PubMed ID: 23793926
[TBL] [Abstract][Full Text] [Related]
40. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]